NCT07476495 Insights on Dissemination of Lung Cancer
| NCT ID | NCT07476495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Oncology & Epidemiology & Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2029-02-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma); * Patients deemed fit for surgical or multimodal treatment; * Informed consent obtained; * Treatment, including multimodal treatment, involving surgery. Exclusion Criteria: * Histology other than adenocarcinoma or squamous cell carcinoma; * Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years; * Age \<18 years; * No need for surgery.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.